Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Cancer Letters
|
November 12, 1996
Monensin and verapamil do not alter intracellular localisation of daunorubicin in multidrug resistant human KB cells
D J Wood, M G Rumsby, J R Warr
Cell Biology International Reports
|
July 1, 1984
Resistance to the mitotic inhibitor NY 3170 in Chinese hamster ovary cells
J R Warr, K Adams, M Anderson, et al.
Cell Biology International Reports
|
May 1, 1986
Verapamil hypersensitivity of vincristine resistant Chinese hamster ovary cell lines
J R Warr, F Brewer, M Anderson, et al.
Cell Biology International
|
May 1, 1993
Relationship between multidrug resistance, hypersensitivity to resistance modifiers and cell volume in Chinese hamster ovary cells
S E Vickers, M W Stow, J R Warr
Cancer Letters
|
November 27, 1995
Gain and loss of hypersensitivity to resistance modifiers in multidrug resistant Chinese hamster ovary cells
J R Warr, D Quinn, M Elend, et al.
Oncology Research
|
January 1, 1996
Reduced daunomycin accumulation in drug-sensitive and multidrug-resistant human carcinoma KB cells following phorbol ester treatment: a potential role for protein kinase C in reducing drug influx
L Drew, N Groome, J R Warr, et al.
British Journal of Cancer
|
December 4, 1998
2-Deoxy-D-glucose preferentially kills multidrug-resistant human KB carcinoma cell lines by apoptosis
S E Bell, D M Quinn, G L Kellett, et al.
Cancer Letters
|
January 22, 2003
LY294002, an inhibitor of phosphatidylinositol-3-kinase, causes preferential induction of apoptosis in human multidrug resistant cells
K M Nicholson, D M Quinn, G L Kellett, et al.
British Journal of Cancer
|
October 3, 1999
Preferential killing of multidrug-resistant KB cells by inhibitors of glucosylceramide synthase
K M Nicholson, D M Quinn, G L Kellett, et al.
Oncology Research
|
January 1, 1994
Changes in protein kinase C subspecies protein expression and activity in a series of multidrug-resistant human KB carcinoma cell lines
L Drew, N Groome, T J Hallam, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Cancer Letters
|
November 12, 1996
Monensin and verapamil do not alter intracellular localisation of daunorubicin in multidrug resistant human KB cells
D J Wood, M G Rumsby, J R Warr
Cell Biology International Reports
|
July 1, 1984
Resistance to the mitotic inhibitor NY 3170 in Chinese hamster ovary cells
J R Warr, K Adams, M Anderson, et al.
Cell Biology International Reports
|
May 1, 1986
Verapamil hypersensitivity of vincristine resistant Chinese hamster ovary cell lines
J R Warr, F Brewer, M Anderson, et al.
Cell Biology International
|
May 1, 1993
Relationship between multidrug resistance, hypersensitivity to resistance modifiers and cell volume in Chinese hamster ovary cells
S E Vickers, M W Stow, J R Warr
Cancer Letters
|
November 27, 1995
Gain and loss of hypersensitivity to resistance modifiers in multidrug resistant Chinese hamster ovary cells
J R Warr, D Quinn, M Elend, et al.
Oncology Research
|
January 1, 1996
Reduced daunomycin accumulation in drug-sensitive and multidrug-resistant human carcinoma KB cells following phorbol ester treatment: a potential role for protein kinase C in reducing drug influx
L Drew, N Groome, J R Warr, et al.
British Journal of Cancer
|
December 4, 1998
2-Deoxy-D-glucose preferentially kills multidrug-resistant human KB carcinoma cell lines by apoptosis
S E Bell, D M Quinn, G L Kellett, et al.
Cancer Letters
|
January 22, 2003
LY294002, an inhibitor of phosphatidylinositol-3-kinase, causes preferential induction of apoptosis in human multidrug resistant cells
K M Nicholson, D M Quinn, G L Kellett, et al.
British Journal of Cancer
|
October 3, 1999
Preferential killing of multidrug-resistant KB cells by inhibitors of glucosylceramide synthase
K M Nicholson, D M Quinn, G L Kellett, et al.
Oncology Research
|
January 1, 1994
Changes in protein kinase C subspecies protein expression and activity in a series of multidrug-resistant human KB carcinoma cell lines
L Drew, N Groome, T J Hallam, et al.
Page
of 3